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A r t i c l e s the immune system that contributes to the molecular mechanisms of virus-induced susceptibility to bacterial superinfection.
RESULTS
Induction of Setdb2 expression by infection with influenza virus
To identify previously unknown regulatory immunological mechanisms involved in virus-induced susceptibility to bacterial superinfection, we infected wild-type mice with influenza virus and collected lung tissue at 18 h after infection. At this early time point, the distribution of viral antigen was limited to a small percentage of epithelial cells (Fig. 1a) . We next performed global expression profiling of lung tissue from infected and uninfected wild-type mice. We identified more than 200 virus-induced genes, many of which were known ISGs 8 (Supplementary Table 1 ). Gene-ontology analysis highlighted enrichment of this group for genes encoding molecules involved in interferon-mediated immune responses, which included the geneontology terms 'interferon alpha and interferon beta signaling' (standard name (Broad Institute), Reactome; systematic name (Broad Institute), M973; P = 0 × 10 0 ) and 'interferon-mediated immunity' (PANTHER protein classification system; systematic name, BP00156; P = 1.50 × 10 −40 ) as well as 'chemokine signaling pathway' (Kyoto Encyclopedia of Genes and Genomes; systematic name, M4844; P = 4.85 × 10 −14 ), 'Toll-like receptor signaling pathway' (Kyoto Encyclopedia of Genes and Genomes; systematic name, M3261; P = 7.89 × 10 −14 ), 'macrophage-mediated immunity' (PANTHER; systematic name, BD00155; P = 5.00 × 10 −12 ) and 'cytokine/ chemokine-mediated immunity' (PANTHER; systematic name, BP00255; P = 1.70 × 10 −8 ). That was confirmed by the enrichment for transcription factor-binding targets of IRF1 (P = 0 × 10 0 ), IRF8 (P = 0 × 10 0 ), IRF7 (P = 1.11 × 10 −16 ) and IRF2 (P = 2.43 × 10 −11 ). Next we analyzed the expression of the mouse orthologs of previously annotated PKMTs 26 . This revealed Setdb2 as the only PKMT with significant induction of expression upon infection with influenza virus (Fig. 1b and , assessed 8 h after treatment (mRNA) or 8 h (d) or 24 h (e,f) after treatment (protein); mRNA results are presented relative to those of untreated wild-type cells, set as 1. Right margin (bottom), size markers in kilodaltons (kDa). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001 (unpaired t-test). Data are from one experiment with three mice per condition (a) or one experiment representative of two independent experiments with similar results (d-f; mean and s.e.m. of biological triplicates) or are pooled from two independent experiments with six mice per condition (b) or two independent experiments (c).
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A r t i c l e s induction of Setdb2 depended on interferon signaling, we infected wild-type mice as well as IFNAR1-deficient (Ifnar1 −/− ) mice, IRF7-deficient (Irf7 −/− ) mice and mice deficient in the type I interferon effector STAT1 (Stat1 −/− mice), each of which lack key molecules required for interferon signaling, with influenza virus. We collected lung tissue at 18 h after infection and detected higher expression of Setdb2 in the lungs of infected wild-type mice than in those of uninfected wild-type mice (Fig. 1c) . In contrast, the induction of Setdb2 was much lower in the lungs of infected Ifnar1 −/− mice than in the lungs of infected wild-type mice (Fig. 1c) , which indicated that type I interferon signaling was essential for the upregulation of Setdb2 in vivo. We also observed lower Setdb2 expression in lungs from infected Irf7 −/− and Stat1 −/− mice than in the lungs of infected wild-type mice (Fig. 1c) . Similarly, infection of primary mouse bone marrow-derived macrophages (BMDMs) with influenza virus resulted in IFNAR1-dependent upregulation of Setdb2 transcription (Fig. 1d) . To investigate protein expression, we raised a monoclonal antibody (clone 7H7F11) against the carboxy-terminal region of mouse Setdb2. Consistent with the expression of mRNA encoding Setdb2, we detected increased Setdb2 protein, in an IFNAR1-dependent manner, after infection of BMDMs (Fig. 1d) . Detection of the known interferon-stimulated protein Zbp1 (DAI) served as a control. Stimulation of BMDMs with IFN-β (type I interferon), IFN-γ (type II interferon) or IFN-λ (type III interferon) revealed that Setdb2 and Zbp1 were induced by the type I interferon as well as by the type II interferon but not the type III interferon (Fig. 1e) . The induction of Setdb2 by the type II interferon was partially dependent on IFNAR1, which indicated a secondary requirement for endogenous type I interferon 27 .
Next we elucidated the expression profiles of Setdb2 mRNA and Setdb2 protein after stimulation of BMDMs with the synthetic lipopeptide and TLR2 agonist Pam 3 CSK 4 , the synthetic viral RNA analog and TLR3 agonist polyinosinic-polycytidylic acid (poly(I:C)) or the TLR4 agonist lipopolysaccharide (LPS) 5 . Treatment of wildtype BMDMs in this way resulted in upregulation of both Setdb2 mRNA and Setdb2 protein (Fig. 1f) . Again, this induction was entirely dependent on type I interferon signaling, as Setdb2 was not induced in Ifnar1 −/− BMDMs (Fig. 1f) . The induction of Setdb2 and Zbp1 upon stimulation with Pam 3 CSK 4 was TLR2 dependent ( Supplementary  Fig. 1 ). In addition to inducing Setdb2, stimulation of wild-type BMDMs with poly(I:C) led to the induction of genes encoding other PKMTs, such as Setd1b and Prdm1, which encodes Blimp-1, a wellstudied regulator of B cells and T cells; however, expression of these genes was not altered upon infection with influenza virus in vivo (Fig. 1b, Supplementary Fig. 2 and Supplementary Table 3) . The elevated expression of Setdb2 mRNA in wild-type BMDMs persisted for at least 24 h (Supplementary Fig. 2 ). Together these data indicated that interferon signaling was required for the induction of Setdb2 both during viral infection and upon stimulation of TLRs.
Modulation of expression of NF-kB target genes by Setdb2
We generated mice with a hypomorphic gene-trap construct of Setdb2 (Setdb2 GT/GT mice) to investigate the biological function of Setdb2 (Supplementary Fig. 3 ). Immunoblot analysis of spleen, lungs and BMDMs showed much less Setdb2 protein in Setdb2 GT/GT mice than in wild-type mice (Fig. 2a) . Next we compared the transcriptomes of untreated and poly(I:C)-stimulated wild-type and Setdb2 GT/GT BMDMs by high-throughput sequencing technology for cDNA (RNASeq). This revealed significant enrichment for known NF-κB target genes among the transcripts upregulated in Setdb2 GT/GT BMDMs (P = 1.35 × 10 −8 (hypergeometric test); Fig. 2b and Supplementary Tables 4 and 5). These NF-κB target genes represented a subset of genes that included Cxcl1, Il12b, S100a8, S100a9, Lcn2, Cxcl2, Chi3l1 and Ltf, each of which encodes a product linked to antibacterial defense. However, other established NF-κB-regulated genes, such as Il6 (which encodes the proinflammatory cytokine interleukin 6 (IL-6)), were not affected (Supplementary Table 4 ). We found no difference between stimulated wild-type BMDMs and stimulated Setdb2 GT/GT BMDMs in their upstream activation of the NF-κB cascade, as measured by degradation of the NF-κB inhibitor IκBα ( Supplementary Fig. 4 ), which suggested that Setdb2 acted downstream of IκBα-mediated activation of NF-κB.
One of the genes found to have particularly high expression in poly(I:C)-stimulated Setdb2 GT/GT BMDMs was Cxcl1. This encodes a key chemoattractant for neutrophils, a type of leukocyte shown to be critically involved in bacterial clearance during superinfection [13] [14] [15] . Thus, we decided to focus on the effects of Setdb2-mediated regulation of Cxcl1. Indeed, stimulation with various TLR agonists resulted in significantly more induction of Cxcl1 transcripts in Setdb2 GT/GT BMDMs than in wild-type control BMDMs (Fig. 2c) . We confirmed that finding at the level of protein secreted by BMDMs (Fig. 2d) . To investigate the effects of type I interferon signaling on Cxcl1 expression, we stimulated BMDMs with poly(I:C) in the presence of IFNAR1-blocking antibodies. This led to diminished levels of Setdb2 mRNA, which correlated inversely with the expression of Cxcl1 mRNA (Supplementary Fig. 5 ). We saw these differences not only in wild-type BMDMs but also in Setdb2 GT/GT BMDMs; this may have been due to the residual levels of Setdb2 in the Setdb2 GT/GT BMDMs and/or another type I interferon-driven Setdb2-independent pathway. Finally, infection with influenza virus strain PR8 led to higher expression of Cxcl1 and a higher concentration of CXCL1 in Setdb2 GT/GT BMDMs than in wild-type BMDMs (Fig. 2e,f) . These data suggested that Setdb2 was a negative regulator of a subset of genes that are targets of NF-κB.
Setdb2 mediates trimethylation of H3K9 at the Cxcl1 promoter Methyltransferases of the SUV39 family 'preferentially' methylate the histone substrate H3K9 (refs. 20,28) . Setdb2 has been shown to catalyze the addition of the repressive mark trimethylated H3K9 (H3K9me3) 23, 24 . We therefore hypothesized that Setdb2 would inhibit Cxcl1 expression by introducing repressive marks in the Cxcl1 promoter region. To determine if Setdb2 was able to bind to the Cxcl1 promoter, we used the Setdb2-specific monoclonal antibody 7H7F11 for chromatin immunoprecipitation (ChIP). We treated BMDMs for 2 h with poly(I:C) and quantified Setdb2-specific enrichment of genomic DNA by real-time PCR. In these ChIP assays we found a significant enrichment in the binding of Setdb2 to the promoter 1,500 npg A r t i c l e s region and exon 1 of Cxcl1 compared with its binding to the promoter sequence of the constitutively expressed control gene Actb (Fig. 3a) . This indicated that Setdb2 bound to the Cxcl1 promoter. Next we addressed whether Setdb2 binding correlated with altered chromatin modifications. For this, we performed ChIP analysis of H3K9me3 in the presence or absence of poly(I:C) stimulation of wild-type or Setdb2 GT/GT BMDMs. Under unstimulated conditions, Setdb2 GT/GT cells had less H3K9me3 at the promoter and exon 1 of Cxcl1 than did wild-type cells (Fig. 3b) . This repressive mark was significantly increased at the Cxcl1 promoter region upon stimulation of wild-type cells with poly(I:C) (Fig. 3b) , consistent with the rapid induction but only transient expression of this gene ( Supplementary  Fig. 6 ). Such an increase in H3K9me3 was absent from Setdb2 GT/GT cells (Fig. 3b) . The promoter of the actively transcribed gene Actb had a low degree of trimethylation of H3K9 in both wild-type BMDMs and Setdb2 GT/GT BMDMs (Fig. 3b) . As a control, we analyzed the presence of the activation mark of acetylated H3K9 (H3K9ac) and, as expected, found enrichment for H3K9ac at the promoter of Actb (Fig. 3c) . Together these data suggested that Setdb2 mediated the repression of Cxcl1 expression at the chromatin level.
Setdb2 deficiency results in exacerbated lung inflammation
Our experiments with Setdb2 GT/GT BMDMs revealed increased expression of CXCL1, which as a chemoattractant for neutrophils is important for efficient pathogen clearance as well as implicated in immunopathologies 29 . To confirm our in vitro findings, we challenged wild-type and Setdb2 GT/GT mice with a model of LPS-induced pulmonary neutrophilia. At 4 h after an intranasal application of LPS, we (Fig. 4a) and more secretion of CXCL1 protein (Fig. 4b) in Setdb2 GT/GT mice than in wild-type mice. The increase in CXCL1 was accompanied by elevated total cell infiltration (Fig. 4c) , as well as neutrophilia in the airways, as measured by cytospin (Fig. 4d) . Macrophage numbers were similar in wild-type mice and Setdb2 GT/GT mice (Fig. 4e) . We concluded that Setdb2 GT/GT mice showed increased infiltration of neutrophils into the lungs in the early phase of inflammation.
Setdb2 mediates susceptibility to bacterial superinfection
The rapid recruitment of neutrophils by the early cytokine CXCL1 is crucial for the prevention of excessive lung inflammation as well as for the clearance of Streptococcus pneumoniae, the most common bacterial agent found in superinfection after primary infection with influenza virus 1, 14, 15, 30 . Therefore, we sought to investigate the response of Setdb2 GT/GT mice in a superinfection model of S. pneumoniae after primary infection with influenza virus. Upon intranasal infection with influenza virus, Setdb2 GT/GT mice underwent more induction of CXCL1 than did wild-type mice (Fig. 5a,b) . In the lungs, CXCL1 is secreted by various cell types, including alveolar macrophages 31 . Indeed, we obtained alveolar macrophages ex vivo from BAL fluid and found that after infection of the cells with influenza virus, Setdb2 GT/GT cells had higher expression of CXCL1 than did cells derived from wild-type mice (Supplementary Fig. 7) , which suggested this cell population as one source of CXCL1 in our infection model in vivo. The expression of other inflammatory mediators, such as CXCL2, IL-6 and IL-10, was similar in BAL fluid from Setdb2 GT/GT mice and that from wild-type mice ( Supplementary  Fig. 8a-c) . Despite the increased amount of CXCL1 in Setdb2 GT/GT mice upon infection with influenza virus, both mouse strains showed similar infiltration of neutrophils into the lungs at this stage of infection (Fig. 5c,d ). Comprehensive profiling of other cell populations in the lung tissue and BAL fluid, including monocytes, macrophages, dendritic cells, alveolar macrophages, natural killer cells, T cells and B cells, revealed no genotype-specific differences in uninfected and influenza virus-infected Setdb2 GT/GT and wild-type mice ( Supplementary Fig. 9a-d) . The viral load was similar in both mouse strains (Supplementary Fig. 10a ). After single infection with S. pneumoniae, Setdb2 GT/GT and wild-type mice exhibited no substantial difference in the induction of CXCL1 (Supplementary Fig. 8d ), the number of neutrophils (Supplementary Fig. 9e,f) or the bacterial burden (Supplementary Fig. 10b) .
Superinfection of influenza virus-infected mice with S. pneumoniae led to a further increase in CXCL1 (Fig. 5b) . This was accompanied by increased infiltration of neutrophils into lung tissue and in the BAL fluid of Setdb2 GT/GT mice but not that of wild-type mice (Fig. 5c,d, Supplementary Fig. 9g,h) . At 2 d after superinfection with S. pneumoniae, mice showed severe signs of pneumonia (Fig. 5e ) and pulmonary edema, as measured by lung wet weight (Fig. 5f) . The gross pathological appearance, including size, weight, number of affected lobes and hemorrhagic lesions, was milder in Setdb2 GT/GT lungs than in wild-type lungs (Fig. 5e,f) . Histopathological analysis of lung sections confirmed and extended the macroscopic findings, with diminished signs of pneumonia, including bronchitis, endothelialitis and inflammatory infiltrates, in Setdb2 GT/GT lungs compared with that in wild-type lungs (Fig. 5g,h ). In line with the ameliorated pathological findings in Setdb2 GT/GT mice at this advanced stage of bacterial superinfection, we found less Il6 mRNA and IL-6 protein in Setdb2 GT/GT mice than in wild-type mice (Fig. 5i,j) and a lower bacterial burden in Setdb2 GT/GT mice than in wild-type control mice (Fig. 5k) . Together these data indicated that influenza virus-induced expression of Setdb2 had a negative effect on the early recruitment of neutrophils, pathogen clearance and tissue integrity during bacterial superinfection.
DISCUSSION
Maintaining a balance between effective pathogen defense and the prevention of excessive inflammation, autoimmunity and immunopathology is the central task of immunoregulation 10, 12 . Signaling via type I interferons and signaling via NF-κB are two important pathways for this process and are subjected to multiple layers of crosstalk, many of which are still poorly understood. In particular, chromatin modifiers are being increasingly recognized as crucial mediators and effectors of immunoregulatory mechanisms.
Here we identified Setdb2 as part of the interferon-mediated immune response that provides a previously unknown layer of regulatory crosstalk between the signaling pathways of type I interferon and NF-κB. The Setdb2-related SUV39 family members Suv39H1, Ehmt1 (Glp) and Ehmt2 (G9a) are involved in immunological processes such as the modulation of ISG expression, the NF-κB pathway and T cell differentiation 17, 19, 32 . Our finding that Setdb2 was itself an ISG indicated a role for Setdb2 in the innate immune response, which might contribute to preventing excessive immunopathology-in particular, infections and/or inflammatory conditions. Notably, single-nucleotide polymorphisms in human SETDB2 have been shown to be associated with increased production of immunoglobulin E and atopic asthma 33 , which supports the proposed role of Setdb2 in regulating inflammation. This evolutionary strategy, however, may turn into a double-edged sword during bacterial superinfection by causing impaired bacterial clearance and severe tissue damage. Signaling via type I interferon has been shown to have a detrimental role in the pathogenesis of virus-induced susceptibility to bacterial superinfection 4, [13] [14] [15] . Accordingly, Setdb2 may be responsible for and mediate at least part of this type I interferon-dependent mechanism.
Chromatin modifiers can be recruited to their targets through specific interactions with transcriptional regulators and/or chromatin-associated factors. We hypothesize that a similar mechanism facilitates the specific recruitment of Setdb2 to the promoters of its target genes to introduce repressive H3K9me3 chromatin marks. However, we cannot exclude the possibility that Setdb2 may recruit other methyltransferases or transcription factors. Likewise, the function of Setdb2 may be determined by non-mutually exclusive cellular and immunological parameters (for example, cell type, inflammatory state and pathogen type) as well as by the complex epigenetic context of multivalent chromatin modifications 34 . Independently of direct histone methylation and in analogy to other PKMTs, Setdb2 may also methylate non-histone protein targets 32, 35 .
Our study has shown that reduced amounts of Setdb2 led to increased production and secretion of CXCL1. Our data suggested that the increased CXCL1 expression and neutrophil recruitment observed in Setdb2 GT/GT mice might have been causally involved in the ameliorated pathogenesis of bacterial superinfection. Neutrophils serve various roles, including the regulation and resolution of inflammation and the elimination of bacterial pathogens 29, 36 . In this study, we observed higher CXCL1 expression in the lungs of influenza virus-infected Setdb2 GT/GT mice than in those of their wild-type counterparts. This alteration in chemokine production and secretion was not sufficient to augment the virus-induced neutrophil response. The increased CXCL1 expression in Setdb2 GT/GT mice manifested phenotypically npg A r t i c l e s only upon superinfection as elevated numbers of neutrophils in the lungs. This could have been due to altered time kinetics of the host response and/or the involvement of additional signals provided by the bacterial superinfection. Together our data suggested that the influenza virus-induced expression of Setdb2 reduced the antibacterial response in wild-type mice, leading to aggravated lung pathology.
Our findings have provided evidence of a regulatory function for Setdb2 in CXCL1 expression, the recruitment of neutrophils, and the pathological outcome of superinfection. However, we cannot exclude the possibility that the products of other Setdb2-modulated genes might have contributed to the improved bacterial clearance and diminished tissue inflammation in Setdb2 GT/GT mice. Our RNA-Seq experiment with poly(I:C) stimulation identified several other genes encoding antibacterial molecules that were upregulated in Setdb2 GT/GT BMDMs. These included genes encoding the chemotactic proteins S100a8 and S100a9 (ref. 37); Marco, a macrophage scavenger receptor linked to the phagocytosis and clearance of bacteria in the lungs 38 ; and Chi3l1, which has been shown to promote both improved clearance of S. pneumoniae and disease tolerance 39 . However, expression profiling of these genes by real-time PCR revealed no difference between superinfected wildtype mice and superinfected Setdb2 GT/GT mice under the experimental conditions of this study (data not shown). Finally, Setdb2 may not only regulate antibacterial responses but also modulate genes encoding molecules involved in disease tolerance in superinfection 40 .
In summary, our study has assigned to Setdb2 a regulatory role in the interferon-mediated immune response and in the pathogenesis of virus-induced susceptibility to bacterial superinfection. Several inhibitors for PKMTs are currently in clinical trials 41 . Thus, Setdb2 could be a therapeutic target for the treatment of superinfections and other inflammatory conditions.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Mice. C57BL/6J mice (wild-type) were obtained from The Jackson Laboratory, and Ifnar1 −/− mice 42 , Irf7 −/− mice 43 , Stat1 −/− mice 44 and Tlr2 −/− Cd36 −/− mice 45, 46 were on a C57BL/6J background. To generate Setdb2 GT/GT mice, the targeting vector pEKF106 was made in Escherichia coli strain EL350 by recombination-mediated genetic engineering with the Lambda RED system 47 . A genomic phage artificial chromosome library (i.e., from the 129/SvevTACfBr genetic background; Roswell Park Cancer Institute mouse phage artificial chromosome library 21; Medical Research Council Geneservice) was screened for the full-length Setdb2 gene with specific cDNA probes. A positive clone, RP21-498J23, was used for recovery of flanking genomic sequences. We generated a 2.3-kilobase genomic fragment introducing an EcoRV restriction site and loxP sites and a cassette for resistance to neomycin (neo r ) with plasmid pLMJ237, for insertion downstream of exon 3. neo r was removed by induction of Cre recombinase with arabinose. Similarly, a 2.9-kilobase genomic fragment harboring the gene-trap cassette flanked with a Flp-recognition target and loxP sites, as well as a heterologous BamHI restriction site, was generated by recombination-mediated genetic engineering with pLTM330. The gene-trap cassette contains a pGK/EM7 dual promoter, a strong splice acceptor site from En2 (which encodes engrailed 2), and Neo reporter gene, followed by a strong polyadenylation signal (Supplementary Fig. 3a) . NotI-linearized targeting vector DNA was transfected into v6.4 embryonic stem cells, a hybrid of the C57BL/6J and 129/SvJae lineages. Transfected embryonic stem cells were selected for neomycin resistance with the aminoglycoside G418, and positive clones were assessed by Southern blot analysis of EcoRV-digested DNA (Supplementary Fig. 3b) . Positive embryonic stem cell clones were microinjected into blastulae and were then transferred to pseudopregnant female mice by standard methods. Mice were genotyped for the presence of the gene-trap cassette by Southern blot hybridization (data not shown) and by amplification of genomic DNA by PCR with the primers 5′-AATGGGCCATATTAGTAGA AGC-3′ and 5′-GATCTTGCTCAAAGGTCACCA-3′ (Supplementary Fig. 3c) . The wild-type allele amplicon was a PCR product of 422 base pairs, while the knocked-in gene-trap amplicon was a PCR product of 516 base pairs. All Setdb2 GT/GT mice used in this study were backcrossed for over ten generations onto a C57BL/6J background.
All mice were kept under specific pathogen-free conditions at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, the Medical University of Vienna, National Cancer institute, the Ohio State University, and/or the Institute for Systems Biology, Seattle. For all experiments, sexand age-matched mice were used. The animal protocols were approved by the Institutional Animal Care and Use Committees of the National Cancer Institute-Frederick, the Ohio State University and the Institute of Systems Biology in Seattle and by the ethical committee of the Medical University of Vienna and the Austrian Federal Ministry of Science and Research.
BMDMs. BMDMs were isolated from C57BL/6J, Ifnar1 −/− and Setdb2 GT/GT mice and were cultured in RPMI medium containing 10% FBS, penicillinstreptomycin-glutamine (10378-016; Life Technologies) and 50 ng/ml recombinant mouse macrophage colony stimulating factor (34-8983-85; eBioscience). BMDMs were stimulated with PAM 3 CSK 4 (tripalmitoyl cysteinyl seryl tetralysine lipopeptide; 500 ng/ml; tlrl-pms; Invivogen), poly(I:C) (6 µg/ml; tlrl-pic; Invivogen), LPS (20 ng/ml; from Salmonella enterica serotype Minnesota; L4641; Sigma), mouse IFN-β (1,000 IU/ml; 12400-1; PBL Interferon Source), mouse IFN-γ (100 ng/ml; 315-05; Peprotech) or IFN-λ2 (100 ng/ml; 4635-ML-025; Biomedica). For in vitro infection with influenza virus strain A/PR/8/34, cells were grown in OPTI-MEM medium (31985-070; Life Tech) containing 4% BSA (A7979; Sigma), 1× MEM vitamins solution (11120-037; Life Tech) and 1 µg/ml TPCK trypsin (T8802; Sigma). To block IFNAR1, we pretreated BMDMs with 20 µg/ml of IFNAR1-specific antibody (MAR1-5A3; BE0241; BioXCell) 48 or with mouse immunoglobulin G1 isotypematched control antibody (MOPC-21; BE0083; BioXCell) 18 h before stimulating the cells with poly(I:C), and we added fresh antibody upon stimulation.
Microarray analysis. Total RNA was extracted with Trizol (Life Technologies) and RNA quality was determined by Bioanalyzer (Agilent). For the experiments in Figure 1b and Supplementary Table 1, RNA was processed for hybridization to GeneChip Mouse Exon 1.0 ST arrays according to the manufacturer's instructions (Affymetrix). Exon-level signal values were generated by Affymetrix Power Tools.
The GenePattern Exon pipeline of the Institute of Systems Biology was used to generate transcript-level expression values. PERL scripts were used to combine and annotate these data. For the experiments in Supplementary Figures 2 and 6 and Supplementary Table 3 , publicly available array expression data derived from poly(I:C)-stimulated BMDMs was downloaded from the website of the Systems Approach to Immunology research program (Systemsimmunology.org). Figure 2b and Supplementary Table 4 , we performed expression analysis by RNA-Seq. BMDMs of each genotype were prepared and then were left unstimulated or were stimulated with poly(I:C) for the appropriate time. RNA was extracted with QIAzol lysis reagent (Qiagen) and libraries were prepared with the Truseq RNA sample preparation kit version 2 according to the manufacturer's instructions (Illumina). An Experion DNA Analysis chip (Biorad) and Qubit Fluorometric Quantitation (Life Technologies) were used for quality control analysis. The samples were multiplexed with nine samples per lane and were run on a 50-base pair single-end flow cell in a Hiseq2000 sequencer (Illumina). RNA-Seq reads were aligned to the mouse genome assembly GRCm38 of the Genome Reference Consortium (assembly mm10 of the UCSC Genome Browser) with the TopHat splice-junction mapper (version 2.0.12) using the mouse gene and transcript annotation from the Ensembl project of genome databases version 70 as reference transcriptome. The TopHat 'max-multihits' option was set to 100, while the length (-L) of the seed substrings of the underlying Bowtie 2 aligner software (version 2. 2.3) were reduced from 20 to 15. Programs from the Cufflinks software package (version 2. 2.1) were used to assemble transcripts, merge transcript assemblies of replicates and samples before final testing for differences in expression with the Cuffdiff program. The default false-discovery rate of 0.05 was left unchanged. Cuffdiff comparisons were post-processed, and quality assessment plots were drawn with the Bioconductor package cummeRbund (version 2.6.1).
RNA sequencing. For the experiments in
Bioinformatics analyses. Gene-ontology enrichment analyses were done with DAVID Bioinformatics Resources 6.7 and the Molecular Signatures Database of Gene Set Enrichment Analysis. Gene Set Enrichment Analysis of transcription factor-binding targets was performed through the use of transcription factor-binding sites as defined in the TRANSFAC public database, version 7.4. The computed robust multi-array average values were subjected to significance analysis of microanalysis with Microarray expression Viewer v4.9. A two-class paired test with default parameters was used and calculated the ∆ value and a cutoff of 3 to identify genes with significant regulation. Heat maps were plotted with software of the R project for statistical computing. Motif scanning for transcription factor-binding sites was performed 3 kilobases upstream and downstream of the transcriptional start site of Setdb2 as described 11 .
A list of NF-κB target genes was compiled with resources from the websites of The Gilmore Lab, Boston University (http://www.bu.edu/nf-kb/ gene-resources/target-genes/) and the Institut de Biologie de Lille et LIFL (http://bioinfo.lifl.fr/NF-KB/#haut%20de%20page), as well as from published literature. The resulting total list of 373 NF-κB target genes (Supplementary Table 5 ) was used to calculate the hypergeometric distribution (with the assumption of a total number of 24,561 coding genes; source, Mouse Genome Informatics) of overlapping genes in the protein-coding genes with significant upregulation of >1.5-fold at one time point or more (P < 0.001).
Real-time PCR. For the measurement of gene expression by real-time PCR, total RNA was isolated with QIAzol lysis reagent (Qiagen) and was reversetranscribed with a First Strand cDNA Synthesis Kit (Fermentas). Subsequently, gene expression was analyzed with Taqman Fast Universal PCR Mastermix and Taqman Gene Expression assays (Setdb2, Mm01318748_m1, Cxcl1, Mm00433859_m1; and Il6, Mm00446190_m1) (Life Technologies), as well as an assay for the gene encoding M protein of influenza virus A/PR/8/34 with oligonucleotides 5′-CATGGAATGGCTAAAGACAAGACC-3′ (forward) and 5′-CCATTAAGGGCATTTTGGACA-3′ (reverse) and the Taqman probe 5′-FAM-TTTGTGTTCACGCTCACCGTGCCCA-BHQ1-3′. Real-time PCR experiments were run on a 7900HT Real-Time PCR system or a StepOnePlus Real-Time PCR system (Life Technologies). Expression data were normalized to those of the housekeeping gene Eef1a1 (encoding eukaryotic translation elongation factor 1 α1).
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Generation of a Setdb2-specific monoclonal antibody. A carboxy-terminal 60-amino acid sequence (amino acid positions 541-600) was fused into a hepatitis B virus carrier protein as an immunogen. This region was amplified by PCR and inserted into a six-histidine-tagged pB-His HBcAg_Linker plasmid 49 . The fusion protein was expressed in E. coli BL21 and was purified on 1-ml HisTrap HP columns (GE Healthcare), followed by a linear imidazole gradient on an ÄKTA FPLC system (GE Healthcare). The fractions were separated by SDS-PAGE and were concentrated with Amicon Ultra 15-3K Centrifugal Filter Devices (Millipore). The immunization and generation of monoclonal B-cell hybridomas was performed by challenging of Setdb2 GT/GT mice subcutaneously three times (every 2 weeks) with 50 µg of purified fusion protein antigen mixed at a ratio of 1:1 with adjuvant, before a final intravenous immunization with 50 µg purified antigen (adjuvant free). Mouse serum and clone pools were tested by immunoblot analysis for the detection of overexpressed and endogenous mouse Setdb2. Clone 7H7F11 yielded the best signal-to-noise performance.
Immunoblot analysis. Protein concentrations of cell lysates and organs were determined with a Coomassie Protein Assay kit (Thermo Scientific). Proteins were separated by SDS-PAGE with NuPAGE Novex 4-12% Bis-Tris Gels (Life Technologies) and analyzed by immunoblot with Westran Clear signal PVDF membranes (Whatman) and the following antibodies: anti-Zbp1 (provided by the Superti-Furga laboratory), anti-Setdb2 (7H7F11; generated in-house in this study), anti-IκBα (sc-371 (C-21), Santa Cruz Biotechnology; and n.4814 (L35A5), Cell Signaling) and anti-actin (A2066; Sigma). Protein size was determined with a PageRuler Prestained Protein Ladder (Thermo Scientific). Proteins were detected with Pierce ECL Western Blotting Substrate (Thermo Scientific) or Amersham ECL Select Western Blotting Detection Reagent (GE Healthcare Life Sciences). Gels were visualized with the chemiluminescent gel documentation system F-ChemiBIS 3.2 (DNR Bio-Imaging Systems).
ELISA. Protein concentrations were determined with a Mouse CXCL1/KC Quantikine ELISA Kit (MKC00B) or Mouse CXCL1/KC DuoSet (DY453), a Mouse CXCL2/MIP-2 DuoSet (DY452), a Mouse IL-6 DuoSet (DY406) (all from R&D Systems) or a Mouse BD OptEIA IL-10 kit (555252; BD Biosciences). ELISAs were performed according to the manufacturer's instructions.
ChIP analysis. BMDMs derived from wild-type or Setdb2 GT/GT mice were left untreated or treated for 2 h with poly(I:C). The same number of cells in each experimental condition were subsequently harvested, fixed for 10 min at room temperature with 1% formaldehyde and lysed in 1% SDS buffer. Chromatin was sheared to an average size of 300 base pairs with an S2X Focusedultrasonicator (Covaris), and the amount of chromatin was adjusted by measurement with an ND-1000 spectrophotometer (NanoDrop) to match wild-type and Setdb2 GT/GT samples before ChIP analysis of histone marks. The chromatin prepared from wild-type or wild-type and Setdb2 GT/GT samples was subjected to ChIP with anti-Setdb2 (7H7F11; described above), anti-H3K9me3 (Ab8898; Abcam) or anti-H3K9ac (07-352; Millipore) according to a published procedure 50 modified by the use of magnetic Dynabeads Protein-G beads (Life Technologies). For mock ChIP controls, empty beads were used. For mock controls in ChIP analysis of Setdb2, the medium used for culture of the hybridoma 7H7F11 was added instead. The ChIP efficiency was controlled by quantitative real-time PCR analysis with the following primers: Cxcl1 promoter region, 5′-CCTCTTCACATGCCTCCCTG-3′ (forward) and 5′-CGGGGATGGAAGCTTGTCTT-3′ (reverse); Cxcl1 exon 1 region, 5′-GTTCCAGCACTCCAGACTCC-3′ (forward) and 5′-AGTGGCGAGACCT ACCTGT-3′ (reverse); Actb promoter region, 5′-CCTCTGGGTGTGGATGTC AC-3′ (forward) and 5′-TGTCCATTCAATCCAGGCCC-3′ (reverse).
LPS-induced pulmonary neutrophilia model. Mice were anesthetized with ketamine and xylazine and were given intranasal administration of 0.4 µg of LPS (E. coli serotype 0111:B4, L4391; Sigma). Four hours later, mice were killed and BAL fluid was obtained by washing of the lungs three times with PBS in a total volume of 1 ml. Total cells in BAL fluid were counted with an improved Neubauer hemocytometer. Cytocentrifuged preparations (Cytospin-4; Shandon Instruments) were stained with Kwik-Diff Stains (Thermo Fisher Scientific), and the percentage of inflammatory cells was determined by morphological examination of at least 300 cells per sample. Figure 1 , mice were anesthetized with ketamine and xylazine and were intranasally infected with 15 µl or 50 µl of PBS containing ~1 × 10 5 plaque-forming units of influenza virus A/PR/8/34 (PR8) (originally obtained from Charles River Laboratories). In all other experiments, mice were infected intranasally with a sublethal dose of influenza virus PR8 (~1 × 10 2 plaque-forming units) or the appropriate dose of S. pneumoniae strain ATCC 6303. Samples for the 16-hour time point in Figure 5 were harvested in the time span corresponding to 14-16 h after superinfection. Bacterial titers were determined from lung homogenates by plating of tenfold serial dilutions on blood agar plates. Lung wet weights were determined with a Pioneer precision balance (Ohaus). Histology. Lung tissue was fixed with either 4% paraformaldehyde or 10% formalin and were embedded in paraffin. Immunohistochemistry was performed on sections 3-4 µm in thickness. Endogenous peroxidase was neutralized (3% H 2 O 2 in PBS), and nonspecific binding was blocked (10% FCS in PBS). Sections were then incubated overnight at 4 °C with goat antibody to influenza virus (5315-0064; Serotec). Bound primary antibody was visualized by a biotin technique with 3,3′ diaminobenzidine as the chromogen (with counterstaining of nuclei with hemalaun).
Infection models. For the lung analyses in
In Figure 5h , histology scores were assigned by a trained pathologist, blinded to group identity, for lung sections stained with hematoxylin and eosin. The severity of inflammation and pneumonia was evaluated on the basis of the presence of interstitial inflammation, alveolar inflammation, pleuritis, bronchitis and endothelitis by the following scoring system: 0, absence; 1, mild; 2, moderate; and 3, severe. Additionally, a score of 1 was added for the presence of pneumonia, edema or thrombi formation, and a score of 0.5 was added for every infiltrate covering 10% of the lung area. The sum of all parameters indicates the total histology score.
Statistical analysis. Statistical differences between experimental groups were determined by an unpaired t-test. If variances (F-test) between the compared data sets were significantly different, an unpaired t-test with Welch's correction was performed. P values of ≤0.05 were considered significant. Graphs and statistical tests were made with GraphPad Prism version 6.
